Cite
HARVARD Citation
Guo, B. et al. (2022). A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapy. Statistical methods in medical research. pp. 1104-1119. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guo, B. et al. (2022). A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapy. Statistical methods in medical research. pp. 1104-1119. [Online].